Helixtalk - Rosalind Franklin University's College Of Pharmacy Podcast
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 115:33:57
- Mas informaciones
Informações:
Sinopsis
Educational podcast presented by the Rosalind Franklin University College of Pharmacy. This podcast is produced by our pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
Episodios
-
022 - Sedation Minimization
03/03/2015 Duración: 28minIn this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.
-
021 - Opioid-Induced Respiratory Depression, Reversal, and Non-Narcotic Alternatives
10/02/2015 Duración: 32minIn this episode, we discuss risk factors for opioid-related adverse events, naloxone (Narcan, Evzio), and a number of non-narcotic agents for neuropathic pain.
-
020 - SMART
20/01/2015 Duración: 22minIn this episode, we summarize and discuss the clinical implications of the SMART trial (Salmeterol Multicenter Asthma Research Trial; Nelson et al, 2006).
-
019 - Immunizations
16/12/2014 Duración: 21minIn this episode, we discuss two controversial topics in the world of immunizations with Dr. Angelo -- the "high-dose" influenza vaccine and the expanded use of PCV13 (Prevnar-13).
-
017 - Overactive bladder
18/11/2014 Duración: 22minIn this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and onabotulinumtoxinA (Botox).
-
016 - New diabetes medications
04/11/2014 Duración: 35minIn this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
-
015 - Cancer Screenings
21/10/2014 Duración: 01h01minIn this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.
-
014 - Midyear Table Talk
07/10/2014 Duración: 31minIn this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program.
-
013 - Obesity Guidelines and Weight Loss Pharmacotherapy
23/09/2014 Duración: 37minIn this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
-
012 - Osteoporosis Guidelines and Two Newer Agents
09/09/2014 Duración: 32minIn this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).
-
011 - Bordetella pertussis
26/08/2014 Duración: 32minIn this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.
-
010 - Pet Peeves
12/08/2014 Duración: 37minIn this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.
-
009 - Combining ACE-I, ARB, and DRIs
29/07/2014 Duración: 21minIn this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.
-
008 - HCAP, HAP, and VAP
15/07/2014 Duración: 28minIn this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).
-
007 - Community-Acquired Pneumonia Guidelines
01/07/2014 Duración: 24minIn this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.
-
006 - Updates to GOLD Guidelines and COPD
17/06/2014 Duración: 27minIn this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and fluticasone/vilanterol (Breo Ellipta).
-
005 - Smoking Cessation
03/06/2014 Duración: 21minIn this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix).
-
004 - P2Y12 Inhibitors, DAPT, and TOAT
20/05/2014 Duración: 30minIn this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).
-
003 - Novel Oral Anticoagulants (NOACs)
06/05/2014 Duración: 26minIn this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).